Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab with Irinotecan, Fluorouracil, and Leucovorin in Newly Diagnosed Stage IV Colorectal Cancer
NCT00020917Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Feb 2001
- Primary completion
- Feb 2004
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of cetuximab in colorectal cancer (CRC), sponsored by Memorial Sloan Kettering Cancer Center. Started Feb 2001; status: completed.
02
Drugs
cetuximab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00020917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00020917.